Utility of recruitment incentives in early Alzheimer’s disease clinical trials
Marina Ritchie, Megan G. Witbracht, Eunji Russ, S. Ahmad Sajjadi, Gaby Thai, Steven Tam, Daniel L Gillen, Joshua D Grill · 2025
Read Utility of recruitment incentives in early Alzheimer’s disease clinical trials by Marina Ritchie, Megan G. Witbracht, Eunji Russ, S. Ahmad Sajjadi, Gaby Thai, Steven Tam, Daniel L Gillen, Joshua D Grill (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712467.txt.
Description
Marina Ritchie and co-authors ask what helps people join early Alzheimer disease trials, in a research paper from 2025. New drugs are in tests, yet sign-up is slow. The team looks at how trial design shapes the choice to take part for people with mild memory loss and their families.
People rated sample trials on a scale of one to seven. The trials varied in drug type, scan result sharing, and whether a study partner had to attend in person. A risk of brain swelling was also varied. The results show which perks draw interest. Trial teams can use the findings to plan fair sign-up.
Catalog record
| CREATOR | Marina Ritchie, Megan G. Witbracht, Eunji Russ, S. Ahmad Sajjadi, Gaby Thai, Steven Tam, Daniel L Gillen, Joshua D Grill |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |